Sun Pharmaceutical Industries Limited

This study is for veterans with prostate cancer that still responds to hormone therapy. It compares three different drugs (abiraterone, enzalutamide, and apalutamide) given alongside standard hormone therapy to see which one controls tumor growth best. About 192 veterans will par…

This study tests a new weekly injection called GL0034 in 285 adults with type 2 diabetes who are overweight or obese. Participants will receive either the study drug or a placebo for about 36 weeks. The main goal is to see if GL0034 helps lower blood sugar levels more than a plac…

This study tests a single dose of a new long-acting diabetes medicine (GL0034) in 40 adults with different levels of kidney function. Researchers want to see if kidney problems change how the drug moves through the body. The goal is to find the right dose for people with kidney i…

This study follows 200 pregnant women who take tildrakizumab for conditions like psoriasis, along with a similar group who don't take the drug. Researchers track pregnancy outcomes and infant health up to one year after birth to check for birth defects or other problems. The goal…